Anesthesiology · Annapolis, MD
NPI
1194163824
Since 2013
Specialty
Anesthesiology
Code 207L00000X
Group practices
7
Medicare group memberships
Hospitals
3
Hospital affiliations
116 Defense Hwy Ste 403
Annapolis, MD, 21401
Phone (410) 571-2946
Groups this clinician bills Medicare through
Medicare paid, 2024
$403K
9,543 services
Medicare patients, 2024
613
Average age 70
Drug cost, 2024
$102K
3,651 prescriptions
Company payments, 2025
$20K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oluseyi A Fadayomi was code 99214 (office e&m - established), 1,562 times for 412 patients. In total Oluseyi A Fadayomi billed 9,543 services in 97 codes, and Medicare paid $403K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,562 | 412 | $93.72 | $146K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 760 | 15 | $0.10 | $75.89 |
| 80307 Drug Tests | Office | 341 | 232 | $59.70 | $20K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 275 | 177 | $153.46 | $42K |
| 64483 Nerve Block Injection - Back | Facility | 232 | 128 | $103.79 | $24K |
| 99204 Office E&M - New | Office | 221 | 221 | $126.57 | $28K |
| 64484 Nerve Block Injection - Back | Facility | 216 | 123 | $47.81 | $10K |
| 62321 Nerve Block Injection - Back | Facility | 93 | 50 | $84.79 | $7,885 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 74 | 61 | $61.45 | $4,547 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 72 | 61 | $205.00 | $15K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 70 | 66 | $194.77 | $14K |
| 64493 Nerve Block Injection - Back | Facility | 65 | 58 | $94.81 | $6,163 |
| 64494 Nerve Block Injection - Back | Facility | 65 | 58 | $52.87 | $3,436 |
| 63650 Neurostimulator - Back | Facility | 58 | 22 | $231.02 | $13K |
| 99213 Office E&M - Established | Office | 48 | 42 | $64.73 | $3,107 |
By year: 2022 $394K for 9,462 services; 2023 $373K for 11,611 services; 2024 $403K for 9,543 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 341 | 232 | $59.70 | $20K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 275 | 177 | $153.46 | $42K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 70 | 66 | $194.77 | $14K |
Medicare prescription drug claims, 2024
In 2024, the drug Oluseyi A Fadayomi prescribed most often to Medicare patients was Gabapentin, with 646 prescriptions and refills. In total Oluseyi A Fadayomi wrote 3,651 Medicare prescriptions that cost $102K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 646 | 688 | 208 | $7,083 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 377 | 377 | 76 | $11K |
| Oxycodone Hcl Generic | 346 | 346 | 84 | $5,408 |
| Cyclobenzaprine Hcl Generic | 314 | 318 | 124 | $2,882 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 305 | 307 | 96 | $7,766 |
| Tramadol Hcl Generic | 269 | 269 | 97 | $2,039 |
| Celecoxib Generic | 186 | 193 | 80 | $2,601 |
| Pregabalin Generic | 185 | 196 | 61 | $3,768 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 97 | 97 | 43 | $1,540 |
| Diclofenac Sodium Generic | 96 | 99 | 43 | $1,706 |
| Tizanidine Hcl Generic | 92 | 124 | 29 | $1,050 |
| Morphine Sulfate Er Morphine Sulfate | 81 | 81 | 17 | $1,214 |
| Trazodone Hcl Generic | 66 | 84 | 13 | $252 |
| Lidocaine Generic | 48 | 51 | 13 | $3,896 |
| Methocarbamol Generic | 46 | 46 | 15 | $491 |
Brand drugs: 103 claims; generic drugs: 3,548 claims; opioid claims: 1,602.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oluseyi A Fadayomi $20K ($20K in general payments such as food, travel and fees) from 14 companies. The largest payer was Boston Scientific Corporation with $19K.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 62 | $19K |
| Medtronic, Inc. MDT | 14 | $238 |
| Saluda Medical Americas, Inc. | 6 | $172 |
| Abbott Laboratories ABT | 6 | $131 |
| Axsome Therapeutics, Inc. AXSM | 3 | $86.24 |
| Pfizer Inc. PFE | 2 | $71.46 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $68.87 |
| Tonix Medicines, Inc. | 1 | $36.33 |
| Globus Medical, Inc. GMED | 2 | $35.29 |
| Nalu Medical, Inc. | 2 | $28.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.